• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盘尾丝虫病的化疗。十三。在加纳北部盘尾丝虫病患者中使用伊维菌素的研究,该地区长期进行病媒控制。

The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.

作者信息

Awadzi K, Dadzie K Y, Kläger S, Gilles H M

机构信息

Onchocerciasis Chemotherapy Research Centre, Hohoe Hospital, Ghana.

出版信息

Trop Med Parasitol. 1989 Sep;40(3):361-6.

PMID:2694315
Abstract

One hundred and ninety eight patients with moderate to heavy infections with Onchocerca volvulus were randomly assigned to receive single doses of 100, 150 or 200 mcg/kg of ivermectin or matching placebo capsules. Detailed systemic, ocular and parasitological examinations were carried out at intervals over a period of one year. Nodules were excised twelve months after treatment to evaluate the effect of the treatment with ivermectin in adult O. volvulus. The three ivermectin-treated groups produced massive reductions in skin microfilariae (over 97%) with low levels being maintained over one year. The 150 and 200 mcg/kg doses were however superior to the 100 mcg/kg dose in achieving a greater reduction in skin microfilarial counts initially and in maintaining significant lower levels throughout the period of observation. There was no difference between the 150 and 200 mcg/kg doses at anytime. The three ivermectin doses were equally effective in the clearance of ocular microfilariae. The proportion of dead adult worms was very high in all treatment groups, which is effected by the successful ten years lasting vector control in northern Ghana. In spite of this superannuation of the worm population, an impact of the treatment with ivermectin on the reproductivity of the parasite could be shown. Systemic total clinical reaction was mild and was similar in the ivermectin treated groups. However, severe symptomatic postural hypotension (SSPH) was limited to patients treated with 150 or 200 mcg/kg of ivermectin. Ocular reactions were mild in all patients and no ocular deficiency occurred.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

198例中重度盘尾丝虫感染患者被随机分配接受单剂量100、150或200微克/千克的伊维菌素或匹配的安慰剂胶囊。在一年的时间里定期进行详细的全身、眼部和寄生虫学检查。治疗12个月后切除结节,以评估伊维菌素治疗对成年盘尾丝虫的效果。三个伊维菌素治疗组的皮肤微丝蚴大量减少(超过97%),且在一年中维持在低水平。然而,150和200微克/千克剂量在最初使皮肤微丝蚴计数有更大减少以及在整个观察期维持显著更低水平方面优于100微克/千克剂量。150和200微克/千克剂量在任何时候都没有差异。三个伊维菌素剂量在清除眼部微丝蚴方面同样有效。所有治疗组中死成虫的比例都非常高,这是受加纳北部成功的十年病媒控制影响。尽管虫群衰老,但仍可显示伊维菌素治疗对寄生虫繁殖力有影响。全身总的临床反应轻微,在伊维菌素治疗组中相似。然而,严重症状性体位性低血压(SSPH)仅限于接受150或200微克/千克伊维菌素治疗的患者。所有患者的眼部反应都很轻微,未出现眼部缺陷。(摘要截短至250字)

相似文献

1
The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.盘尾丝虫病的化疗。十三。在加纳北部盘尾丝虫病患者中使用伊维菌素的研究,该地区长期进行病媒控制。
Trop Med Parasitol. 1989 Sep;40(3):361-6.
2
The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.盘尾丝虫病的化疗X. MK-933(伊维菌素)四种单剂量治疗方案治疗人类盘尾丝虫病的评估
Ann Trop Med Parasitol. 1985 Feb;79(1):63-78.
3
Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis.一项在治疗盘尾丝虫病中使用安慰剂对照的三剂量伊维菌素比较研究的眼科结果。
Trop Med Parasitol. 1989 Sep;40(3):355-60.
4
A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus.在加纳阿苏本德盘尾丝虫病疫源地进行的伊维菌素社区试验。一、对微丝蚴库及盘尾丝虫传播的影响
Trop Med Parasitol. 1989 Sep;40(3):367-74.
5
The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.盘尾丝虫病的化学疗法XX:伊维菌素与阿苯达唑联合使用
Trop Med Parasitol. 1995 Dec;46(4):213-20.
6
The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana.盘尾丝虫病的化疗。十一。伊维菌素、乙胺嗪和安慰剂在加纳北部人类盘尾丝虫病中的双盲对照研究。
Ann Trop Med Parasitol. 1986 Aug;80(4):433-42. doi: 10.1080/00034983.1986.11812044.
7
Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.高剂量乙胺嗪或单剂量伊维菌素治疗盘尾丝虫病:微丝蚴水平及副作用
Trop Med Parasitol. 1988 Mar;39(1):19-24.
8
Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.药物控制六年后人宿主中盘尾丝虫微丝蚴的种群动态
J Vector Borne Dis. 2008 Mar;45(1):29-37.
9
Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.单次剂量莫昔克丁与伊维菌素治疗加纳、利比里亚和刚果民主共和国盘尾丝虫感染的随机、对照、双盲 3 期临床试验。
Lancet. 2018 Oct 6;392(10154):1207-1216. doi: 10.1016/S0140-6736(17)32844-1. Epub 2018 Jan 18.
10
The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.阿莫卡嗪治疗非洲盘尾丝虫病的安全性和有效性以及伊维菌素对治疗的临床和寄生虫学反应的影响。
Ann Trop Med Parasitol. 1997 Apr;91(3):281-96. doi: 10.1080/00034989761139.

引用本文的文献

1
Onchocerciasis drug development: from preclinical models to humans.盘尾丝虫病药物研发:从临床前模型到人体。
Parasitol Res. 2021 Dec;120(12):3939-3964. doi: 10.1007/s00436-021-07307-4. Epub 2021 Oct 13.
2
A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.一项随机、单剂量递增、伊维菌素对照、双盲的莫昔克丁治疗盘尾丝虫病的研究。
PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2953. doi: 10.1371/journal.pntd.0002953. eCollection 2014 Jun.
3
Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment.
对伊维菌素治疗反应不佳的社区和个体中的旋毛形线虫β-微管蛋白的基因分析。
Int J Parasitol Drugs Drug Resist. 2012 Feb 12;2:20-8. doi: 10.1016/j.ijpddr.2012.01.005. eCollection 2012 Dec.
4
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.确定伊维菌素治疗河盲症的疗效欠佳反应。
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16716-21. doi: 10.1073/pnas.0906176106. Epub 2009 Sep 17.
5
Drug treatment of tropical parasitic infections: recent achievements and developments.热带寄生虫感染的药物治疗:近期成果与进展
Drugs. 2000 Nov;60(5):985-95. doi: 10.2165/00003495-200060050-00002.
6
Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.盘尾丝虫病患者反复使用伊维菌素治疗后不良反应减少。
Doc Ophthalmol. 1990 Oct;75(3-4):215-24. doi: 10.1007/BF00164834.
7
Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.伊维菌素。关于其抗丝虫活性、药代动力学特性及盘尾丝虫病临床疗效的综述。
Drugs. 1991 Oct;42(4):640-58. doi: 10.2165/00003495-199142040-00007.